New research suggests that obesity can leave chemical imprints within helper immune cells long after a person’s body weight has decreased.
The finding could clarify why health risks associated with obesity may continue even after successful weight loss.
Claudio Mauro, professor of inflammation and ageing at the University of Birmingham, connected previous obesity with lasting changes in immune behaviour.
His researchers identified the strongest signs of this enduring immune signal in samples of blood, fat tissue and mouse cells.
The pattern was also seen following medication-led weight loss, in genetic obesity and in mice whose diets were switched back.
How CD4 T cells remembered obesity
The research focused on CD4 T cells, helper immune cells that direct defence responses and inflammation.
While obesity was present, these cells shifted towards an effector memory state, a rapid-response mode that may drive inflammation.
Following weight loss, their levels and behaviour did not rapidly return to the quieter pattern observed in lean controls.
As obesity affects one in eight people globally, the delayed reset has implications well beyond an individual clinic.
DNA chemical tags
This immune memory was not caused by genes being rewritten, but by DNA methylation: chemical tags that regulate gene activity.
These tags altered how genes worked without changing the DNA sequence, leaving cells to behave as though previous conditions remained relevant.
Lower DNA methylation close to a gene involved in cellular clean-up attracted attention because it could help maintain the changed immune state.
Another gene linked with cellular ageing suggested that ageing-related immune features may last longer than anticipated.
Cell clean-up and ageing
Two cellular processes appeared to carry this memory onwards, beginning with autophagy, the clean-up system cells use to break down waste.
In mice that shed fat after following a high-fat diet, this clean-up signal remained unusually active in inflammatory T cells.
Immune senescence, a form of ageing that makes immune cells less adaptable, also stayed elevated after weight loss.
These processes may protect cells during brief periods, but their long-term persistence could leave immune responses unbalanced for years.
Evidence from human participants
The human evidence drew on four groups of patients, volunteers and surgical tissue donors, offering the team several ways to examine the same immune issue.
One group had Alstrom syndrome, a rare genetic condition that causes early obesity, while another group used weight-loss injections.
A 10-week exercise study improved fitness, but the CD4 memory pattern did not reset in either blood or fat tissue.
These findings do not mean exercise lacks value; rather, they indicate that immune recovery operates on a longer timescale.
Fatty acids as triggers
Laboratory experiments identified palmitate, a saturated fat molecule often found in high-fat diets, as a possible trigger.
Palmitate caused CD4 T-cell membranes to become more structured and less fluid, potentially altering signals travelling from the cell surface to the nucleus.
When these signals reached DNA regulatory regions, methyl tags fell near a gene involved in cellular clean-up in the cells tested.
Oleic acid – a widely occurring unsaturated fat – behaved differently, indicating that not all fats create the same immune effect.
Removing genes in mice
Experiments in mice examined STK26 more closely by removing the gene and giving the animals either standard or high-fat diets.
In the absence of this gene, inflammatory effector memory T cells increased less after an immune challenge.
Autophagy was also reduced, indicating that the gene helped drive the clean-up pathway associated with the memory.
However, ageing-like immune cells still increased, meaning that blocking a single route did not completely restore balance.
Why obesity-related disease risk persists
Disease risk can persist when immune cells continue to send inflammatory signals into tissues responsible for sugar handling, fat processing and repair.
“The findings suggest that short-term weight loss may not immediately reduce the risk of some disease conditions associated with obesity, including type 2 diabetes and some cancers. Instead, ongoing weight management following loss will see the ‘obesity memory’ slowly fade,” said Mauro.
The researchers estimated that this fading process may take 5 to 10 years, a limit that future long-term studies need to examine.
Directions for future research
One potential treatment lead concerns SGLT2 inhibitors, diabetes medicines that may help immune cells clear aged cells.
Associated research found that a drug from this class helped lower senescent cells – aged cells that may promote inflammation – in obese mice.
Researchers must still establish through carefully designed trials whether SGLT2 inhibitors can safely accelerate immune recovery after weight loss in humans.
Long-term studies will need to determine whether SGLT2 inhibitors, or other approaches targeting cellular clean-up, lower disease risk after sustained weight loss.
The enduring immune imprint brings together weight history, DNA tagging, cellular clean-up and immune ageing in a single slow recovery process.
After substantial weight loss, care may need to include inflammation monitoring for years while researchers seek safe ways to hasten immune recovery.






Comments
No comments yet. Be the first to comment!
Leave a Comment